Geneos Wealth Management’s iShares Core S&P US Value ETF IUSV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.83M Buy
37,444
+13,136
+54% +$1.38M 0.09% 248
2025
Q4
$2.49M Sell
24,308
-99
-0.4% -$10K 0.06% 318
2025
Q3
$2.44M Buy
24,407
+1,165
+5% +$113K 0.06% 314
2025
Q2
$2.2M Sell
23,242
-24,318
-51% -$2.19M 0.05% 354
2025
Q1
$4.39M Buy
47,560
+26,688
+128% +$2.5M 0.06% 323
2024
Q4
$1.93M Sell
20,872
-1,364
-6% -$131K 0.07% 292
2024
Q3
$2.12M Sell
22,236
-1,156
-5% -$106K 0.08% 273
2024
Q2
$2.06M Sell
23,392
-33
-0.1% -$2.91K 0.09% 243
2024
Q1
$2.12M Buy
23,425
+42
+0.2% +$3.62K 0.1% 239
2023
Q4
$1.97M Buy
23,383
+74
+0.3% +$5.76K 0.1% 233
2023
Q3
$1.74M Sell
23,309
-3,061
-12% -$240K 0.09% 237
2023
Q2
$2.06M Sell
26,370
-1,439
-5% -$107K 0.11% 214
2023
Q1
$2.05M Sell
27,809
-340
-1% -$25K 0.12% 193
2022
Q4
$1.99M Buy
28,149
+1,793
+7% +$125K 0.12% 180
2022
Q3
$1.65M Sell
26,356
-5,616
-18% -$388K 0.11% 187
2022
Q2
$2.16M Sell
31,972
-771
-2% -$55.4K 0.11% 202
2022
Q1
$2.48M Sell
32,743
-3,300
-9% -$247K 0.11% 200
2021
Q4
$2.75M Sell
36,043
-4,593
-11% -$341K 0.1% 202
2021
Q3
$2.92M Sell
40,636
-4,399
-10% -$319K 0.11% 190
2021
Q2
$3.27M Buy
45,035
+317
+0.7% +$22.8K 0.13% 176
2021
Q1
$3.2M Sell
44,718
-283
-0.6% -$18.6K 0.09% 224
2020
Q4
$3.12M Sell
45,001
-159,445
-78% -$9.34M 0.13% 178
2020
Q3
$10.9M Buy
204,446
+4,166
+2% +$228K 0.56% 33
2020
Q2
$10.2M Buy
200,280
+15,896
+9% +$812K 0.57% 33
2020
Q1
$8.46M Buy
184,384
+16,662
+10% +$958K 0.57% 32
2019
Q4
$10.6M Buy
167,722
+3,778
+2% +$228K 0.56% 29
2019
Q3
$9.42M Buy
163,944
+31,607
+24% +$1.8M 0.56% 32
2019
Q2
$7.5M Buy
132,337
+2,284
+2% +$127K 0.46% 43
2019
Q1
$7.13M Buy
130,053
+18,332
+16% +$980K 0.47% 43
2018
Q4
$5.44M Buy
111,721
+11,151
+11% +$593K 0.4% 57
2018
Q3
$5.67M Buy
100,570
+18,748
+23% +$1.05M 0.38% 60
2018
Q2
$4.39M Buy
81,822
+26,967
+49% +$1.45M 0.34% 81
2018
Q1
$2.91M Buy
54,855
+18,227
+50% +$1.01M 0.25% 104
2017
Q4
$2.03M Buy
36,628
+23,259
+174% +$1.25M 0.18% 132
2017
Q3
$699K Buy
13,369
+10,265
+331% +$527K 0.07% 245
2017
Q2
$158K Buy
3,104
+716
+30% +$36.2K 0.02% 560
2017
Q1
$120K Hold
2,388
0.01% 612
2016
Q4
$117K Buy
2,388
+890
+59% +$42.1K 0.02% 572
2016
Q3
$69K Buy
1,498
+1,348
+899% +$61.9K 0.01% 695
2016
Q2
$6K Hold
150
﹤0.01% 1465
2016
Q1
$6K Buy
+150
New +$6.09K ﹤0.01% 1443

Other funds holding IUSV

Geneos Wealth Management's IUSV Position: Q1 2026 in Review

Geneos Wealth Management increased its iShares Core S&P US Value ETF (IUSV) stake by 54% in Q1 2026, buying an estimated $1.38M and bringing the position to 37,444 shares worth $3.83M. The position accounts for 0.09% of the portfolio, ranked #248.

Geneos Wealth Management first reported a position in IUSV in Q1 2016 and has held it in 41 quarters since. The position peaked at $10.9M in Q3 2020. 786 funds tracked by Wall St. Rank hold IUSV as of Q1 2026.

  • Geneos Wealth Management held 37,444 shares of iShares Core S&P US Value ETF worth $3.83M as of Q1 2026.
  • Geneos Wealth Management bought 13,136 iShares Core S&P US Value ETF shares in Q1 2026, an estimated $1.38M.
  • iShares Core S&P US Value ETF made up 0.09% of Geneos Wealth Management's portfolio in Q1 2026, its #248 holding.
  • Geneos Wealth Management first reported a position in iShares Core S&P US Value ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's iShares Core S&P US Value ETF position peaked at $10.9M in Q3 2020.
  • 786 funds tracked by Wall St. Rank held iShares Core S&P US Value ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.